• Tue news: Pfizer explores sale of hospital drugs unit. FDA declines full approval of Ocaliva. AZ better than expected Q3 results. Pfizer, Lilly telehealth platforms draw scrutiny. 23andMe cutting lays off 40%. See more on our front page

How many leaving CardioRenal?

Quote








anonymous said:
It wont be long before the FDA, DEA investigation lands Bayer a huge fine and reps in serious trouble. Pay is same as anywhere else. Worse now because inflation has others paying more. RUN!!!
Click to expand...
What the hell are you talking about? This company is the most compliant company I
have ever worked for hands down.
 




















































This division is a complete dumpster fire, and my worst nightmare of what made me hesitant of leaving my last company. Feast or famine IC, no Medicare part D coverage, and if it’s covered the co-pay is outrageous.

Corrupt to its core, let’s give away Kerendia to CA, NY, and TX Medicaid recipients, while getting slim to no reimbursement from Medicaid, and act like it’s a good thing that the company is making no money, but let’s pay the reps like they are actually working for their bonus.

Isn’t this a business!? Those who are actually making the company money, should get paid the most, not those who are getting worthless Medicaid scripts. But not at Bayer, all they care about here is showing growth of HCP usage, not making any money back on the drug, and then sharing targets and calling 1 NRX, 2 NRX so all the idiots upstairs can feel like they are doing something and can show positive growth to Wall Street.

A vast majority of my scripts are Medicare, and commercial, with a PA, and the company is actually getting a reimbursement worth something.

Take the Medicaid NRX volume out of the equation, then everyone killing it, would be at the bottom.

Who knew coming to Bayer you would be making huge bonuses on Medicaid scripts, no other company I have worked for even counted those scripts.

Disaster by design, #onebayer
 




BINGO!

QUOTE="anonymous, post: 6783282"]This division is a complete dumpster fire, and my worst nightmare of what made me hesitant of leaving my last company. Feast or famine IC, no Medicare part D coverage, and if it’s covered the co-pay is outrageous.

Corrupt to its core, let’s give away Kerendia to CA, NY, and TX Medicaid recipients, while getting slim to no reimbursement from Medicaid, and act like it’s a good thing that the company is making no money, but let’s pay the reps like they are actually working for their bonus.

Isn’t this a business!? Those who are actually making the company money, should get paid the most, not those who are getting worthless Medicaid scripts. But not at Bayer, all they care about here is showing growth of HCP usage, not making any money back on the drug, and then sharing targets and calling 1 NRX, 2 NRX so all the idiots upstairs can feel like they are doing something and can show positive growth to Wall Street.

A vast majority of my scripts are Medicare, and commercial, with a PA, and the company is actually getting a reimbursement worth something.

Take the Medicaid NRX volume out of the equation, then everyone killing it, would be at the bottom.

Who knew coming to Bayer you would be making huge bonuses on Medicaid scripts, no other company I have worked for even counted those scripts.

Disaster by design, #onebayer[/QUOTE]
 




Does anyone understand the fractional scripts? We see many .1 or.2 for NBRX. So I need 10 .1’s to finally get a script? Ha! Fishing with a hole in my net here. I see Whole numbers for FTP’s but the only FTPs that count are through Iquvia- so we are missing all the non reporting pharmacies even with voucher. Don’t tell me 90% accuracy. Bayer chose to not pay for data other than Iquvia. So I’m not working for commission, I’m working for salary.
 




The only people who do well are the original people who got to hand pick every target in their territory to grow.

Everyone else brought on with expansion got left overs and there is no way to keep up and they refuse to re-align territories.

Random shared targets that help some but not others. One of worse bonus structure, strategies and alignment I’ve seen in my entire career.

I’ll just keep doing little collecting a high base salary until they layoff and I’ll collect a severe car and find something else.
 




anonymous said:
Does anyone understand the fractional scripts? We see many .1 or.2 for NBRX. So I need 10 .1’s to finally get a script? Ha! Fishing with a hole in my net here. I see Whole numbers for FTP’s but the only FTPs that count are through Iquvia- so we are missing all the non reporting pharmacies even with voucher. Don’t tell me 90% accuracy. Bayer chose to not pay for data other than Iquvia. So I’m not working for commission, I’m working for salary.
Click to expand...

Iquivia is hands the worse reporting tool in the industry.. it’s embarrassing how fucked some of the reps are getting. Also this .01 or .02 what the fuck is that? Either it’s zero scripts or it’s 1 script. bayer has to step
Up and change this.
 




Top Bottom
Back
Quote